Company Search:
Advanced Search
Sponsored Links
Nattopharma ASA Company Snapshot
Nattopharma ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nattopharma ASA with three other pharmaceutical manufacturers in Europe: Enzymatica AB (publ) of Sweden (2017 sales of 59.45 million Swedish Kronor [US$7.26 million] ), Swedencare AB (publ) of Sweden (85.49 million Swedish Kronor [US$10.43 million] ), and Biotec Pharmacon ASA (66.69 million Norwegian Kroner [US$8.64 million] ).

Sales Analysis. During the year ended December of 2017, sales at Nattopharma ASA were NOK 66.42 million (US$8.61 million). This is an increase of 28.1% versus 2016, when the company's sales were NOK 51.83 million. This was the fifth consecutive year of sales increases at Nattopharma ASA (and since 2012, sales have increased a total of 489%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nattopharma ASA
  Stock Performance Chart for Nattopharma ASA
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 8.70
(Figures in Norwegian Kroner)
1 Week -0.6%   13 Weeks -7.9%  
4 Weeks -11.2%   52 Weeks -16.3%  
Nattopharma ASA Key Data:
  Ticker: NATTO Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 66,418,000
(Year Ending Jan 2018).
Employees: 13
  Currency: Norwegian Kroner Market Cap: 157,730,417
  Fiscal Yr Ends: December Shares Outstanding: 18,129,933
  Share Type: Ordinaere Aksje Closely Held Shares: 7,778,700
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.